Insider Transactions in Q2 2024 at Travere Therapeutics, Inc. (TVTX)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 08
2024
|
Roy D. Baynes |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+17.33%
|
-
|
|
May 08
2024
|
Suzanne Louise Bruhn |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+22.61%
|
-
|
|
May 08
2024
|
Timothy Coughlin |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+11.71%
|
-
|
|
May 08
2024
|
Gary A Lyons |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+11.3%
|
-
|
|
May 08
2024
|
Jeffrey A Meckler |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+7.43%
|
-
|
|
May 08
2024
|
Sandra Poole |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+21.67%
|
-
|
|
May 08
2024
|
Brinkley Ruth Williams |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+25.24%
|
-
|
|
May 08
2024
|
John A Orwin |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+18.37%
|
-
|
|
May 08
2024
|
Ron Squarer |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+18.37%
|
-
|
|
Apr 11
2024
|
Christopher R. Cline CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
54
-0.08%
|
$324
$6.74 P/Share
|